Skip to content

Net margin at other companies

Castle Biosciences logo
Castle BiosciencesCSTL
-3.8%-10.2pp
Guardant Health logo
Guardant HealthGH
-40.1%-8.1pp
Biodesix, Inc. logo
Biodesix, Inc.BDSX
-33.3%-9.3pp
Insight Molecular Diagnostics Inc. Common Stock logo
Insight Molecular Diagnostics Inc. Common StockIMDX
-2,454.6%+4,017pp
Fulgent Genetics, Inc. logo
Fulgent Genetics, Inc.FLGT
-23%+43.3pp
Personalis, Inc. logo
Personalis, Inc.PSNL
-148.1%+154pp

Other financials

Income statement

See full
Revenue$1.3M+51.7%
Gross profit-$369.0K+49.0%
Operating income-$12.1M+3.0%
Net income-$13.9M+48.3%
EPS (diluted)-$0.10+60.0%

Balance sheet

See full
Cash & equivalents$27.9M+10.6%
Total debt$1.6M-35.1%
Total equity$4.0M+174%
Total assets$34.1M+3.9%

Cash flow

See full
Operating cash flow-$12.1M+2.9%
CapEx$215.0K+131%
Free cash flow-$12.3M+1.9%

Valuation

See full
Market cap$204.13M+58.5%
Enterprise value$177.85M+78.0%
P/S39.8×+10.2×

Profitability

See full
Gross margin-66.8%
Operating margin-959.6%-133pp
FCF margin-1,099.6%

Returns & leverage

See full
Return on equity-710.6%
Debt / equity0.4×
Current ratio1.1×+0.3×

Where this comes from

Calculated from Lucid Diagnostics’s reported figures.

Based on trailing twelve months.

The official record: Lucid Diagnostics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Lucid Diagnostics's net margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Lucid Diagnostics's net margin?
Lucid Diagnostics (LUCD) reported net margin of -876.7% in Q1 2026.
How has Lucid Diagnostics's net margin changed year-over-year?
Lucid Diagnostics's net margin increased by 40.8% year-over-year, from -1,481.5% to -876.7%.
What is the long-term trend for Lucid Diagnostics's net margin?
Over 3 years (2022 to 2025), Lucid Diagnostics's net margin has grown at a -56.4% compound annual growth rate (CAGR), from -14,899.5% to -1,232.7%.
What does net margin mean?
Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.